Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 52
Filter
Add more filters










Publication year range
1.
NPJ Precis Oncol ; 8(1): 2, 2024 Jan 03.
Article in English | MEDLINE | ID: mdl-38172524

ABSTRACT

Successful treatment of solid cancers relies on complete surgical excision of the tumor either for definitive treatment or before adjuvant therapy. Intraoperative and postoperative radial sectioning, the most common form of margin assessment, can lead to incomplete excision and increase the risk of recurrence and repeat procedures. Mohs Micrographic Surgery is associated with complete removal of basal cell and squamous cell carcinoma through real-time margin assessment of 100% of the peripheral and deep margins. Real-time assessment in many tumor types is constrained by tissue size, complexity, and specimen processing / assessment time during general anesthesia. We developed an artificial intelligence platform to reduce the tissue preprocessing and histological assessment time through automated grossing recommendations, mapping and orientation of tumor to the surgical specimen. Using basal cell carcinoma as a model system, results demonstrate that this approach can address surgical laboratory efficiency bottlenecks for rapid and complete intraoperative margin assessment.

2.
RNA Biol ; 20(1): 296-305, 2023 01.
Article in English | MEDLINE | ID: mdl-37287312

ABSTRACT

Gene editing using CRISPR/Cas (clustered regularly interspaced palindromic repeats/CRISPR-associated) is under development as a therapeutic tool for the modification of genes in eukaryotic cells. While much effort has focused on CRISPR/Cas9 systems from Streptococcus pyogenes and Staphylococcus aureus, alternative CRISPR systems have been identified from non-pathogenic microbes, including previously unknown class 2 systems, adding to a diverse toolbox of CRISPR/Cas enzymes. The Cas12e enzymes from non-pathogenic Deltaproteobacteria (CasX1, DpeCas12e) and Planctomycetes (CasX2, PlmCas12e) are smaller than Cas9, have a selective protospacer adjacent motif (PAM), and deliver a staggered cleavage cut with a 5-7 nucleotide overhang. We investigated the impact of guide RNA spacer length and alternative PAM sequences on cleavage activity to determine optimal conditions for PlmCas12e cleavage of the cellular gene CCR5 (CC-Chemokine receptor-5). CCR5 encodes the CCR5 coreceptor used by human immunodeficiency virus-type 1 (HIV-1) to infect target cells. A 32 base-pair deletion in CCR5 (CCR5-[Formula: see text]32) is responsible for HIV-1 resistance and reported cures following bone marrow transplantation. Consequently, CCR5 has been an important target for gene editing utilizing CRISPR/Cas. We determined that CCR5 cleavage activity varied with the target site, spacer length, and the fourth nucleotide in the previously described PAM sequence, TTCN. Our analyses demonstrated a PAM preference for purines (adenine, guanine) over pyrimidines (thymidine, cytosine) in the fourth position of the CasX2 PAM. This improved understanding of CasX2 cleavage requirements facilitates the development of therapeutic strategies to recreate the CCR5-[Formula: see text]32 mutation in haematopoietic stem cells.


Subject(s)
CRISPR-Cas Systems , Gene Editing , Humans , Mutation , RNA/genetics , Nucleotides , Receptors, CCR5/genetics
3.
bioRxiv ; 2023 Jan 02.
Article in English | MEDLINE | ID: mdl-36711562

ABSTRACT

CRISPR/Cas is under development as a therapeutic tool for the cleavage, excision, and/or modification of genes in eukaryotic cells. While much effort has focused on CRISPR/Cas from Streptococcus pyogenes (SpCas9) and Staphylococcus aureus (SaCas9), alternative CRISPR systems have been identified using metagenomic datasets from non-pathogenic microbes, including previously unknown class 2 systems, adding to a diverse toolbox of gene editors. The Cas12e (CasX1, CasX2) endonucleases from non-pathogenic Deltaproteobacteria (DpeCas12e) and Planctomycetes (PlmCas12e) are more compact than SpCas9, have a more selective protospacer adjacent motif (PAM) requirement, and deliver a staggered cleavage cut with 5-7 base overhangs. We investigated varying guide RNA (spacer) lengths and alternative PAM sequences to determine optimal conditions for PlmCas12e cleavage of the cellular gene CCR5 (CC-Chemokine receptor-5). CCR5 encodes one of two chemokine coreceptors required by HIV-1 to infect target cells, and a mutation of CCR5 (delta-32) is responsible for HIV-1 resistance and reported cures following bone marrow transplantation. Consequently, CCR5 has been an important target for gene editing utilizing CRISPR, TALENs, and ZFNs. We determined that CCR5 cleavage activity varied with the target site, guide RNA length, and the terminal nucleotide in the PAM sequence. Our analyses demonstrated a PlmCas12e PAM preference for purines (A, G) over pyrimidines (T, C) in the fourth position of the CasX2 PAM (TTCN). These analyses have contributed to a better understanding of CasX2 cleavage requirements and will position us more favorably to develop a therapeutic that creates the delta-32 mutation in the CCR5 gene in hematopoietic stem cells.

4.
Oncoimmunology ; 11(1): 2141011, 2022.
Article in English | MEDLINE | ID: mdl-36338148

ABSTRACT

Cancer immunotherapy approaches target signaling pathways that are highly synonymous between CD4 and CD8 T-cell subsets and, therefore, often stimulate nonspecific lymphocyte activation, resulting in cytotoxicity to otherwise healthy tissue. The goal of our study was to identify intrinsic modulators of basic T lymphocyte activation pathways that could discriminately bolster CD8 anti-tumor effector responses. Using a Tbc1d10c null mouse, we observed marked resistance to a range of tumor types conferred by Tbc1d10c deficiency. Moreover, tumor-bearing Tbc1d10c null mice receiving PD-1 or CTLA-4 monotherapy exhibited a 33% or 90% cure rate, respectively. While Tbc1d10c was not expressed in solid tumor cells, Tbc1d10c disruption selectively augmented CD8 T-cell activation and cytotoxic effector responses and adoptive transfer of CD8 T cells alone was sufficient to recapitulate Tbc1d10c null tumor resistance. Mechanistically, Tbc1d10c suppressed CD8 T-cell activation and anti-tumor function by intersecting canonical NF-κB pathway activation via regulation of Map3k3-mediated IKKß phosphorylation. Strikingly, none of these cellular or molecular perturbations in the NF-κB pathway were featured in Tbc1d10c null CD4 T cells. Our findings identify a Tbc1d10c-Map3k3-NF-κB signaling axis as a viable therapeutic target to promote CD8 T-cell anti-tumor immunity while circumventing CD4 T cell-associated cytotoxicity and NF-κB activation in tumor cells.


Subject(s)
NF-kappa B , Neoplasms , Mice , Animals , NF-kappa B/metabolism , CD8-Positive T-Lymphocytes , Lymphocyte Activation , Neoplasms/therapy , T-Lymphocyte Subsets/metabolism , GTPase-Activating Proteins/genetics
5.
J Immunol ; 206(8): 1776-1783, 2021 04 15.
Article in English | MEDLINE | ID: mdl-33789982

ABSTRACT

Regulatory T (Treg) cells have an essential role in maintaining immune homeostasis, in part by suppressing effector T cell functions. Phosphoinositide-dependent kinase 1 (PDK1) is a pleiotropic kinase that acts as a key effector downstream of PI3K in many cell types. In T cells, PDK1 has been shown to be critical for activation of NF-κB and AKT signaling upon TCR ligation and is therefore essential for effector T cell activation, proliferation, and cytokine production. Using Treg cell-specific conditional deletion, we now demonstrate that PDK1 is also essential for Treg cell suppressive activity in vivo. Ablation of Pdk1 specifically in Treg cells led to systemic, lethal, scurfy-like inflammation in mice. Genome-wide analysis confirmed that PDK1 is essential for the regulation of key Treg cell signature gene expression and, further, suggested that PDK1 acts primarily to control Treg cell gene expression through regulation of the canonical NF-κB pathway. Consistent with these results, the scurfy-like phenotype of mice lacking PDK1 in Treg cells was rescued by enforced activation of NF-κB downstream of PDK1. Therefore, PDK1-mediated activation of the NF-κB signaling pathway is essential for regulation of Treg cell signature gene expression and suppressor function.


Subject(s)
3-Phosphoinositide-Dependent Protein Kinases/metabolism , Lymphoproliferative Disorders/genetics , T-Lymphocytes, Regulatory/immunology , 3-Phosphoinositide-Dependent Protein Kinases/genetics , Animals , CD4 Antigens/metabolism , Cell Proliferation , Cells, Cultured , Forkhead Transcription Factors/genetics , Forkhead Transcription Factors/metabolism , Immunosuppression Therapy , Lymphocyte Activation , Mice , Mice, Knockout , NF-kappa B/metabolism , Signal Transduction , Transcriptome
6.
F1000Res ; 9: 281, 2020.
Article in English | MEDLINE | ID: mdl-32528662

ABSTRACT

The discovery of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) system has revolutionized gene editing research. Through the repurposing of programmable RNA-guided CRISPR-associated (Cas) nucleases, CRISPR-based genome editing systems allow for the precise modification of specific sites in the human genome and inspire novel approaches for the study and treatment of inherited and acquired human diseases. Here, we review how CRISPR technologies have stimulated key advances in dermatologic research.  We discuss the role of CRISPR in genome editing for cutaneous disease and highlight studies on the use of CRISPR-Cas technologies for genodermatoses, cutaneous viruses and bacteria, and melanoma. Additionally, we examine key limitations of current CRISPR technologies, including the challenges these limitations pose for the widespread therapeutic application of CRISPR-based therapeutics.


Subject(s)
CRISPR-Cas Systems , Clustered Regularly Interspaced Short Palindromic Repeats , Dermatology , Gene Editing , Skin Diseases/therapy , Genetic Therapy , Humans , Skin Diseases/genetics
7.
AIDS Res Hum Retroviruses ; 36(10): 862-874, 2020 10.
Article in English | MEDLINE | ID: mdl-32640832

ABSTRACT

Gene editing approaches using CRISPR/Cas9 are being developed as a means for targeting the integrated HIV-1 provirus. Enthusiasm for the use of gene editing as an anti-HIV-1 therapeutic has been tempered by concerns about the specificity and efficacy of this approach. Guide RNAs (gRNAs) that target conserved sequences across a wide range of genetically diverse HIV-1 isolates will have greater clinical utility. However, on-target efficacy should be considered in the context of off-target cleavage events as these may comprise an essential safety parameter for CRISPR-based therapeutics. We analyzed a panel of Streptococcus pyogenes Cas9 (SpCas9) gRNAs directed to the 5' and 3' long terminal repeat (LTR) regions of HIV-1. We used in vitro cleavage assays with genetically diverse HIV-1 LTR sequences to determine gRNA activity across HIV-1 clades. Lipid-based transfection of gRNA/Cas9 ribonucleoproteins was used to assess targeting of the integrated HIV-1 proviral sequence in cells (in vivo). For both the in vitro and in vivo experiments, we observed increased efficiency of sequence disruption through the simultaneous use of two distinct gRNAs. Next, CIRCLE-Seq was utilized to identify off-target cleavage events using genomic DNA from cells with integrated HIV-1 proviral DNA. We identified a gRNA targeting the U3 region of the LTR (termed SpCas9-127HBX2) with broad cleavage efficiency against sequences from genetically diverse HIV-1 strains. Based on these results, we propose a workflow for identification and development of anti-HIV CRISPR therapeutics.


Subject(s)
HIV Infections , HIV-1 , CRISPR-Cas Systems , Gene Editing , HIV Infections/genetics , HIV-1/genetics , Humans , RNA, Guide, Kinetoplastida/genetics
8.
JCI Insight ; 3(15)2018 08 09.
Article in English | MEDLINE | ID: mdl-30089718

ABSTRACT

Epithelial cells are the first line of defense against external dangers, and contribute to induction of adaptive immunity including Th17 responses. However, it is unclear whether specific epithelial signaling pathways are essential for the development of robust IL-17-mediated immune responses. In mice, the development of psoriatic inflammation induced by imiquimod required keratinocyte TRAF6. Conditional deletion of TRAF6 in keratinocytes abrogated dendritic cell activation, IL-23 production, and IL-17 production by γδ T cells at the imiquimod-treated sites. In contrast, hapten-induced contact hypersensitivity and papain-induced IgE production were not affected by loss of TRAF6. Loss of psoriatic inflammation was not solely due to defective imiquimod sensing, as subcutaneous administration of IL-23 restored IL-17 production but did not reconstitute psoriatic pathology in the mutant animals. Thus, TRAF6 was required for the full development of IL-17-mediated inflammation. Therefore, epithelial TRAF6 signaling plays an essential role in both triggering and propagating IL-17-mediated psoriatic inflammation.


Subject(s)
Intraepithelial Lymphocytes/immunology , Keratinocytes/metabolism , Psoriasis/immunology , TNF Receptor-Associated Factor 6/metabolism , Animals , Cells, Cultured , Disease Models, Animal , Female , Humans , Imiquimod/immunology , Interleukin-17/immunology , Interleukin-17/metabolism , Intraepithelial Lymphocytes/metabolism , Keratinocytes/immunology , Male , Mice , Mice, Knockout , Primary Cell Culture , Psoriasis/pathology , Receptors, Interleukin-17/immunology , Receptors, Interleukin-17/metabolism , Signal Transduction/immunology , Skin/cytology , Skin/immunology , Skin/pathology , TNF Receptor-Associated Factor 6/genetics , TNF Receptor-Associated Factor 6/immunology
9.
Nature ; 559(7712): 114-119, 2018 07.
Article in English | MEDLINE | ID: mdl-29950719

ABSTRACT

Prolonged exposure to microbial products such as lipopolysaccharide can induce a form of innate immune memory that blunts subsequent responses to unrelated pathogens, known as lipopolysaccharide tolerance. Sepsis is a dysregulated systemic immune response to disseminated infection that has a high mortality rate. In some patients, sepsis results in a period of immunosuppression (known as 'immunoparalysis')1 characterized by reduced inflammatory cytokine output2, increased secondary infection3 and an increased risk of organ failure and mortality4. Lipopolysaccharide tolerance recapitulates several key features of sepsis-associated immunosuppression5. Although various epigenetic changes have previously been observed in tolerized macrophages6-8, the molecular basis of tolerance, immunoparalysis and other forms of innate immune memory has remained unclear. Here we perform a screen for tolerance-associated microRNAs and identify miR-221 and miR-222 as regulators of the functional reprogramming of macrophages during lipopolysaccharide tolerization. Prolonged stimulation with lipopolysaccharide in mice leads to increased expression of miR-221 and mir-222, both of which regulate brahma-related gene 1 (Brg1, also known as Smarca4). This increased expression causes the transcriptional silencing of a subset of inflammatory genes that depend on chromatin remodelling mediated by SWI/SNF (switch/sucrose non-fermentable) and STAT (signal transducer and activator of transcription), which in turn promotes tolerance. In patients with sepsis, increased expression of miR-221 and miR-222 correlates with immunoparalysis and increased organ damage. Our results show that specific microRNAs can regulate macrophage tolerization and may serve as biomarkers of immunoparalysis and poor prognosis in patients with sepsis.


Subject(s)
Chromatin Assembly and Disassembly/genetics , Immunity, Innate/immunology , Immunologic Memory/genetics , Immunologic Memory/immunology , MicroRNAs/genetics , Animals , DNA Helicases/metabolism , Female , HEK293 Cells , Humans , Immune Tolerance/genetics , Immune Tolerance/immunology , Immunity, Innate/genetics , Inflammation/genetics , Inflammation/immunology , Inflammation Mediators/immunology , Lipopolysaccharides/immunology , Macrophages/immunology , Male , Mice , Nuclear Proteins/metabolism , RAW 264.7 Cells , STAT Transcription Factors/metabolism , Sepsis/immunology , Shock, Septic/immunology , Transcription Factors/metabolism
10.
Cell Rep ; 22(10): 2654-2666, 2018 03 06.
Article in English | MEDLINE | ID: mdl-29514094

ABSTRACT

ECSIT is a mitochondrial complex I (CI)-associated protein that has been shown to regulate the production of mitochondrial reactive oxygen species (mROS) following engagement of Toll-like receptors (TLRs). We have generated an Ecsit conditional knockout (CKO) mouse strain to study the in vivo role of ECSIT. ECSIT deletion results in profound alteration of macrophage metabolism, leading to a striking shift to reliance on glycolysis, complete disruption of CI activity, and loss of the CI holoenzyme and multiple subassemblies. An increase in constitutive mROS production in ECSIT-deleted macrophages prevents further TLR-induced mROS production. Surprisingly, ECSIT-deleted cells accumulate damaged mitochondria because of defective mitophagy. ECSIT associates with the mitophagy regulator PINK1 and exhibits Parkin-dependent ubiquitination. However, upon ECSIT deletion, we observed increased mitochondrial Parkin without the expected increase in mitophagy. Taken together, these results demonstrate a key role of ECSIT in CI function, mROS production, and mitophagy-dependent mitochondrial quality control.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Electron Transport Complex I/metabolism , Macrophages/metabolism , Mitophagy , Animals , Energy Metabolism , Gene Deletion , Glycolysis , Membrane Potential, Mitochondrial , Mice, Inbred C57BL , Mitochondria/metabolism , Oxidative Phosphorylation , Protein Binding , Protein Stability , Reactive Oxygen Species/metabolism , Substrate Specificity , Ubiquitin-Protein Ligases/metabolism
11.
J Immunol ; 200(7): 2362-2371, 2018 04 01.
Article in English | MEDLINE | ID: mdl-29459403

ABSTRACT

CD4+Foxp3+ regulatory T cells (Tregs) are essential regulators of immune responses. Perturbation of Treg homeostasis or function can lead to uncontrolled inflammation and autoimmunity. Therefore, understanding the molecular mechanisms involved in Treg biology remains an active area of investigation. It has been shown previously that the NF-κB family of transcription factors, in particular, the canonical pathway subunits, c-Rel and p65, are crucial for the development, maintenance, and function of Tregs. However, the role of the alternative NF-κB pathway components, p100 and RelB, in Treg biology remains unclear. In this article, we show that conditional deletion of the p100 gene, nfkb2, in Tregs, resulted in massive inflammation because of impaired suppressive function of nfkb2-deficient Tregs. Surprisingly, mice lacking RelB in Tregs did not exhibit the same phenotype. Instead, deletion of both relb and nfkb2 rescued the inflammatory phenotype, demonstrating an essential role for p100 as an inhibitor of RelB in Tregs. Our data therefore illustrate a new role for the alternative NF-κB signaling pathway in Tregs that has implications for the understanding of molecular pathways driving tolerance and immunity.


Subject(s)
Immune Tolerance/immunology , NF-kappa B p52 Subunit/genetics , Nuclear Proteins/genetics , T-Lymphocytes, Regulatory/immunology , Transcription Factor RelB/genetics , Animals , Autoimmunity/immunology , Cell Differentiation , Cells, Cultured , Endonucleases , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B p52 Subunit/metabolism , Nuclear Proteins/metabolism , Proto-Oncogene Proteins c-rel/metabolism , T-Lymphocytes, Regulatory/cytology , Transcription Factor RelA/metabolism , Transcription Factor RelB/metabolism
12.
Am J Clin Dermatol ; 19(1): 119-126, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28801732

ABSTRACT

BACKGROUND: Alopecia areata (AA) is an autoimmune disease characterized by non-scarring alopecia with T-cell infiltration at the affected hair follicle. OBJECTIVE: Our aim was to study the potential link between hepatitis B virus (HBV) antigen exposure and AA. METHODS: Two pediatric patients with AA following hepatitis B vaccination were identified in a general dermatology clinic. A bioinformatics analysis and an electronic medical record (EMR) database query were performed at the University of Rochester Medical Center to identify patients with AA, coexisting viral infections, vaccinations, or interferon (IFN) therapy in order to determine if the presence of AA and these conditions was higher than in AA patients without these associated conditions or therapy. RESULTS: An increased frequency of AA among those who received the HBV surface protein antigen [odds ratio (OR) 2.7, p < 0.0001] was identified, and an independent analysis revealed an increased frequency of AA in those receiving IFN-ß treatment (OR 8.1, p < 0.05). One potential antigenic target identified was SLC45A2, a melanosomal transport protein important in skin and hair pigmentation. The longest potential vaccine peptide fragment match (8-mer) was to a segment of natural killer (NK) cell inhibitory receptors, KIR3DL2 and KIR3DL1. Predictive modeling of major histocompatibility complex (MHC)-peptide binding demonstrated potential binding of this peptide to MHC relevant to AA. LIMITATIONS: The results will need to be verified in additional patient databases allowing analysis of temporal relationships, and with molecular experiments of the identified antigens. CONCLUSIONS: Our data confirm associations between viral infection and IFN treatment with AA. It establishes that the hepatitis B surface protein antigen has shared epitopes with human killer immunoglobulin-like receptors.


Subject(s)
Alopecia Areata/immunology , Autoimmune Diseases/immunology , Hepatitis B Vaccines/immunology , Hepatitis B virus/immunology , Immunosuppressive Agents/therapeutic use , Alopecia Areata/drug therapy , Antigens, Viral/immunology , Autoimmune Diseases/drug therapy , Child, Preschool , Female , Hair Follicle/immunology , Humans , Infant
13.
Carcinogenesis ; 39(3): 418-428, 2018 03 08.
Article in English | MEDLINE | ID: mdl-29186361

ABSTRACT

Squamous cell carcinoma (SCC) of the skin is a keratinocyte malignancy characterized by tumors presenting on sun-exposed areas with surgery being the mainstay treatment. Despite advances in targeted therapy in other skin cancers, such as basal cell carcinoma and melanoma, there have been no such advances in the treatment of SCC. This is partly due to an incomplete knowledge of the pathogenesis of SCC. We have recently identified a protein kinase C-associated kinase (PKK) as a potential tumor suppressor in SCC. We now describe a novel conditional PKK knockout mouse model, which demonstrates that PKK deficiency promotes SCC formation during chemically induced tumorigenesis. Our results further support that PKK functions as a tumor suppressor in skin keratinocytes and is important in the pathogenesis of SCC of the skin. We further define the interactions of keratinocyte PKK with TP63 and NF-κB signaling, highlighting the importance of this protein as a tumor suppressor in SCC development.


Subject(s)
Carcinoma, Squamous Cell/genetics , Cell Transformation, Neoplastic/genetics , Keratinocytes/pathology , Protein Serine-Threonine Kinases/genetics , Skin Neoplasms/genetics , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Carcinogens/toxicity , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/pathology , Genes, Tumor Suppressor , Humans , Keratinocytes/drug effects , Mice , Mice, Knockout , Pyridines/toxicity , Signal Transduction/physiology , Skin Neoplasms/chemically induced , Skin Neoplasms/pathology
14.
Cell ; 170(6): 1096-1108.e13, 2017 Sep 07.
Article in English | MEDLINE | ID: mdl-28886380

ABSTRACT

Regulatory T cells (Tregs) play a pivotal role in the inhibition of anti-tumor immune responses. Understanding the mechanisms governing Treg homeostasis may therefore be important for development of effective tumor immunotherapy. We have recently demonstrated a key role for the canonical nuclear factor κB (NF-κB) subunits, p65 and c-Rel, in Treg identity and function. In this report, we show that NF-κB c-Rel ablation specifically impairs the generation and maintenance of the activated Treg (aTreg) subset, which is known to be enriched at sites of tumors. Using mouse models, we demonstrate that melanoma growth is drastically reduced in mice lacking c-Rel, but not p65, in Tregs. Moreover, chemical inhibition of c-Rel function delayed melanoma growth by impairing aTreg-mediated immunosuppression and potentiated the effects of anti-PD-1 immunotherapy. Our studies therefore establish inhibition of NF-κB c-Rel as a viable therapeutic approach for enhancing checkpoint-targeting immunotherapy protocols.


Subject(s)
Immunotherapy/methods , Melanoma/immunology , Melanoma/pathology , NF-kappa B/antagonists & inhibitors , Proto-Oncogene Proteins c-rel/antagonists & inhibitors , T-Lymphocytes, Regulatory/immunology , Animals , Disease Models, Animal , Female , Male , Melanoma/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , NF-kappa B/metabolism
15.
Immunity ; 47(3): 450-465.e5, 2017 09 19.
Article in English | MEDLINE | ID: mdl-28889947

ABSTRACT

Both conventional T (Tconv) cells and regulatory T (Treg) cells are activated through ligation of the T cell receptor (TCR) complex, leading to the induction of the transcription factor NF-κB. In Tconv cells, NF-κB regulates expression of genes essential for T cell activation, proliferation, and function. However the role of NF-κB in Treg function remains unclear. We conditionally deleted canonical NF-κB members p65 and c-Rel in developing and mature Treg cells and found they have unique but partially redundant roles. c-Rel was critical for thymic Treg development while p65 was essential for mature Treg identity and maintenance of immune tolerance. Transcriptome and NF-κB p65 binding analyses demonstrated a lineage specific, NF-κB-dependent transcriptional program, enabled by enhanced chromatin accessibility. These dual roles of canonical NF-κB in Tconv and Treg cells highlight the functional plasticity of the NF-κB signaling pathway and underscores the need for more selective strategies to therapeutically target NF-κB.


Subject(s)
Cell Lineage/genetics , NF-kappa B/metabolism , T-Lymphocytes, Regulatory/immunology , T-Lymphocytes, Regulatory/metabolism , Transcription, Genetic , Animals , Autoimmunity/genetics , Autoimmunity/immunology , Binding Sites , Biomarkers , Cell Differentiation , Cell Survival/genetics , Cell Survival/immunology , Cluster Analysis , Cytokines/metabolism , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation , Homeostasis/genetics , Homeostasis/immunology , Immune Tolerance , Immunophenotyping , Inflammation/genetics , Inflammation/immunology , Inflammation/metabolism , Lymphocyte Activation , Mice , Mice, Transgenic , NF-kappa B/genetics , Nucleotide Motifs , Phenotype , Protein Binding , Signal Transduction , T-Lymphocytes, Regulatory/cytology , Transcription Factor RelA/genetics , Transcription Factor RelA/metabolism , Transcriptome
16.
Oncotarget ; 7(46): 75954-75967, 2016 Nov 15.
Article in English | MEDLINE | ID: mdl-27732942

ABSTRACT

Cutaneous T-cell Lymphoma (CTCL) is a rare non-Hodgkin's lymphoma that can affect the skin, blood, and lymph nodes, and can metastasize at late stages. Novel therapies that target all affected disease compartments and provide longer lasting responses while being safe are needed. One potential therapeutic target is NF-κB, a regulator of immune responses and an important participant in carcinogenesis and cancer progression. As a transcription factor, NF-κB targets genes that promote cell proliferation and survival. Constitutive or aberrant activation of NF-κB is encountered in many types of cancer, including CTCL.Recently, while analyzing gene-expression profiles of a variety of small molecule compounds that target NF-κB, we discovered the tetracycline family of antibiotics, including doxycycline, to be potent inhibitors of the NF-κB pathway. Doxycycline is well-tolerated, safe, and inexpensive; and is commonly used as an antibiotic and anti-inflammatory for the treatment a multitude of medical conditions.In our current study, we show that doxycycline induces apoptosis in a dose dependent manner in multiple different cell lines from patients with the two most common subtypes of CTCL, Mycosis Fungoides (MF) and Sézary Syndrome (SS). Similar results were found using primary CD4+ T cells from a patient with SS. Doxycycline inhibits TNF induced NF-κB activation and reduces expression of NF-κB dependent anti-apoptotic proteins, such as BCL2α. Furthermore, we have identified that doxycycline induces apoptosis through reactive oxygen species.


Subject(s)
Apoptosis/drug effects , Doxycycline/pharmacology , NF-kappa B/antagonists & inhibitors , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Aged , Caspase 8/metabolism , Cell Line, Tumor , Female , Humans , Lymphoma, T-Cell, Cutaneous/metabolism , Lymphoma, T-Cell, Cutaneous/pathology , Male , Phosphorylation , Reactive Oxygen Species/metabolism , Sezary Syndrome/metabolism , Signal Transduction/drug effects , T-Lymphocytes/pathology , Tumor Necrosis Factor-alpha/pharmacology , Young Adult
17.
Cell Rep ; 15(8): 1615-23, 2016 05 24.
Article in English | MEDLINE | ID: mdl-27184845

ABSTRACT

Asymmetric cell division (ACD) in a perpendicular orientation promotes cell differentiation and organizes the stratified epithelium. However, the upstream cues regulating ACD have not been identified. Here, we report that phosphoinositide-dependent kinase 1 (PDK1) plays a critical role in establishing ACD in the epithelium. Production of phosphatidyl inositol triphosphate (PIP3) is localized to the apical side of basal cells. Asymmetric recruitment of atypical protein kinase C (aPKC) and partitioning defective (PAR) 3 is impaired in PDK1 conditional knockout (CKO) epidermis. PDK1(CKO) keratinocytes do not undergo calcium-induced activation of aPKC or IGF1-induced activation of AKT and fail to differentiate. PDK1(CKO) epidermis shows decreased expression of Notch, a downstream effector of ACD, and restoration of Notch rescues defective expression of differentiation-induced Notch targets in vitro. We therefore propose that PDK1 signaling regulates the basal-to-suprabasal switch in developing epidermis by acting as both an activator and organizer of ACD and the Notch-dependent differentiation program.


Subject(s)
3-Phosphoinositide-Dependent Protein Kinases/metabolism , Asymmetric Cell Division , Cell Differentiation , Epidermal Cells , Epidermis/enzymology , Animals , Calcium/pharmacology , Cells, Cultured , Embryo, Mammalian/cytology , Embryo, Mammalian/enzymology , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice, Knockout , Phenotype , Phosphatidylinositols/metabolism , Phosphorylation/drug effects , Protein Kinase C , Receptors, Notch/metabolism , Signal Transduction
19.
PLoS One ; 11(2): e0148987, 2016.
Article in English | MEDLINE | ID: mdl-26859749

ABSTRACT

Toll-like receptors (TLRs) are innate immune receptors that sense a variety of pathogen-associated molecular patterns (PAMPs) by interacting with them and subsequently initiating signal transduction cascades that elicit immune responses. TLR11 has been shown to interact with two known protein PAMPs: Salmonella and E. coli flagellin FliC and Toxoplasma gondii profilin-like protein. Given the highly divergent biology of these pathogens recognized by TLR11, it is unclear whether common mechanisms are used to recognize these distinct protein PAMPs. Here we show that TLR11 interacts with these two PAMPs using different receptor domains. Furthermore, TLR11 binding to flagellin and profilin exhibits differential dependency on pH and receptor ectodomain cleavage.


Subject(s)
Flagellin/metabolism , Profilins/metabolism , Toll-Like Receptors/immunology , Animals , Blotting, Western , Cathepsins/metabolism , Cloning, Molecular , HEK293 Cells , Humans , Mice , Protein Interaction Domains and Motifs , Recombinant Proteins , Toxoplasma
20.
Nat Commun ; 7: 10255, 2016 Jan 08.
Article in English | MEDLINE | ID: mdl-26743335

ABSTRACT

Mechanistic target of rapamycin complex 1 (mTORC1), defined by the presence of Raptor, is an evolutionarily conserved and nutrient-sensitive regulator of cellular growth and other metabolic processes. To date, all known functions of Raptor involve its scaffolding mTOR kinase with substrate. Here we report that mTORC1-independent ('free') Raptor negatively regulates hepatic Akt activity and lipogenesis. Free Raptor levels in liver decline with age and in obesity; restoration of free Raptor levels reduces liver triglyceride content, through reduced ß-TrCP-mediated degradation of the Akt phosphatase, PHLPP2. Commensurately, forced PHLPP2 expression ameliorates hepatic steatosis in diet-induced obese mice. These data suggest that the balance of free and mTORC1-associated Raptor governs hepatic lipid accumulation, and uncover the potentially therapeutic role of PHLPP2 activators in non-alcoholic fatty liver disease.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Hepatocytes/metabolism , Lipogenesis/genetics , Liver/metabolism , Non-alcoholic Fatty Liver Disease/genetics , Obesity/genetics , Oncogene Protein v-akt/metabolism , Animals , Blood Glucose/metabolism , Blotting, Western , Chromatography, Gel , Diet, High-Fat , Fatty Liver/genetics , Fatty Liver/metabolism , Immunoprecipitation , Insulin/metabolism , Mechanistic Target of Rapamycin Complex 1 , Mice , Multiprotein Complexes , Non-alcoholic Fatty Liver Disease/metabolism , Obesity/metabolism , Phosphoprotein Phosphatases/metabolism , Regulatory-Associated Protein of mTOR , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction , TOR Serine-Threonine Kinases , Triglycerides/metabolism , beta-Transducin Repeat-Containing Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...